Hydrochlorothiazide reduces urinary calcium excretion in a child with Lowe syndrome

Area of Science:

• Pediatric Nephrology
• Genetics and Rare Diseases

Background:

• Lowe syndrome is a rare genetic disorder associated with significant risks of nephrocalcinosis and nephrolithiasis.
• Hypercalciuria is a primary driver of these renal complications in affected children.
• Current interventions like increased fluid intake and acidosis correction have limited efficacy.

Purpose of the Study:

• To investigate the safety and efficacy of thiazide diuretics in managing hypercalciuria in a child with Lowe syndrome.
• To address the unmet need for effective treatments for renal complications in Lowe syndrome.

Main Methods:

• A case report detailing the treatment of a child diagnosed with Lowe syndrome.
• Administration of thiazide diuretics to manage hypercalciuria.
• Monitoring of urinary calcium excretion and renal health indicators.

Main Results:

• The child with Lowe syndrome showed successful management of hypercalciuria following thiazide treatment.
• Thiazide diuretics were found to be effective in reducing urinary calcium excretion in this patient.
• No significant adverse effects were observed during the treatment period.

Conclusions:

• Thiazide diuretics represent a viable and effective therapeutic option for managing hypercalciuria in children with Lowe syndrome.
• This case challenges previous concerns regarding the efficacy and safety of thiazides in this population.
• Further research is warranted to confirm these findings in a larger cohort.